Labcorp completes acquisition of myriad autoimmune's vectra testing business

Burlington, n.c.--(business wire)--labcorp (nyse: lh), a leading global life sciences company, today announced that it has closed its acquisition of select operating assets and intellectual property (ip) from myriad genetics' autoimmune business unit, including the vectra® rheumatoid arthritis (ra) assay. earlier this year, labcorp entered into a definitive agreement to acquire myriad's vectra test, related ip and other ra assets, bolstering its scientific leadership in rheumatology. specific t
LH Ratings Summary
LH Quant Ranking